ONTOLOGY REPORT - ANNOTATIONS
| Term: | methamphetamine |
|
| Accession: | CHEBI:6809
|
browse the term
|
| Definition: | An amphetamine that has formula C10H15N. |
| Synonyms: | exact_synonym: | (2S)-N-methyl-1-phenylpropan-2-amine |
| | related_synonym: | (+)-(S)-N-alpha-dimethylphenethylamine; (S)-N,alpha-dimethylbenzeneethanamine; (alphaS)-N,alpha-dimethylbenzeneethanamine; C10H15N; CN[C@@H](C)Cc1ccccc1; InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1; InChIKey=MYWUZJCMWCOHBA-VIFPVBQESA-N; d-1-phenyl-2-methylaminopropane; d-N-methylamphetamine; d-deoxyephedrine; d-desoxyephedrine; d-phenylisopropylmethylamine; methyl-beta-phenylisopropylamine |
| | xref_casrn: | 537-46-2 |
| | xref: | Beilstein:2207147 "Beilstein Registry Number"; ChEMBL:775152 "ChEMBL COMPOUND"; ChemIDplus:537-46-2 "CAS Registry Number"; DrugBank:DB01577 "DrugBank"; KEGG COMPOUND:537-46-2 "CAS Registry Number"; KEGG COMPOUND:C07164 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D008694 |
| | xref: | NIST Chemistry WebBook:537-46-2 "CAS Registry Number"; Wikipedia:Methamphetamine "Wikipedia" |
|
|
methamphetamine
|
| G |
Aanat |
aralkylamine N-acetyltransferase |
|
decreases expression |
EXP |
10 |
106,709,371 |
106,713,683 |
RGD:6480464 |
CTD |
| G |
Aanat |
aralkylamine N-acetyltransferase |
|
multiple interactions |
EXP |
10 |
106,709,371 |
106,713,683 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
increases expression |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
increases expression |
EXP |
14 |
80,769,000 |
80,809,809 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
EXP |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
multiple interactions |
EXP |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
affects response to substance |
ISO |
10 |
39,729,805 |
39,778,106 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actg1 |
actin, gamma 1 |
|
decreases expression |
EXP |
10 |
109,773,489 |
109,776,334 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
multiple interactions |
ISO |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
decreases expression |
ISO |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
affects response to substance |
ISO |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
affects response to substance |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Ak1 |
adenylate kinase 1 |
|
decreases expression |
EXP |
2 |
19,821,482 |
19,822,544 |
RGD:6480464 |
CTD |
| G |
Ak5 |
adenylate kinase 5 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
|
increases expression |
EXP |
17 |
77,316,456 |
77,332,903 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
multiple interactions |
EXP |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
affects localization |
EXP |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
increases expression |
EXP |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
decreases expression |
EXP |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
decreases expression |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Aoah |
acyloxyacyl hydrolase (neutrophil) |
|
affects response to substance |
ISO |
17 |
51,475,254 |
51,722,447 |
RGD:6480464 |
CTD |
| G |
Apex2 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
increases expression |
EXP |
X |
39,811,484 |
39,832,225 |
RGD:6480464 |
CTD |
| G |
Apex2l1 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2-like 1 |
|
increases expression |
EXP |
14 |
72,314,446 |
72,315,996 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
multiple interactions |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
multiple interactions |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
multiple interactions |
EXP |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
increases expression |
EXP |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression |
EXP |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression |
EXP |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
increases response to substance |
ISO |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
increases expression |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Astn2 |
astrotactin 2 |
|
affects response to substance |
ISO |
5 |
82,124,461 |
83,128,927 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
decreases expression |
EXP |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5h |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d |
|
decreases expression |
EXP |
10 |
105,474,107 |
105,499,413 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
decreases expression |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
decreases expression |
ISO |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
decreases expression |
EXP |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Ca1 |
carbonic anhydrase I |
|
increases expression |
EXP |
2 |
88,166,412 |
88,210,693 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
affects response to substance |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases expression |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases expression |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases expression |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
|
decreases expression |
ISO |
5 |
157,980,877 |
158,080,682 |
RGD:6480464 |
CTD |
| G |
Car5b |
carbonic anhydrase 5b, mitochondrial |
|
increases expression |
EXP |
X |
51,241,437 |
51,290,433 |
RGD:6480464 |
CTD |
| G |
Car5b |
carbonic anhydrase 5b, mitochondrial |
|
multiple interactions |
EXP |
X |
51,241,437 |
51,290,433 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
decreases expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
multiple interactions |
EXP |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
decreases expression |
EXP |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases response to substance |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases methylation |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Cct2 |
chaperonin containing TCP1, subunit 2 (beta) |
|
decreases expression |
EXP |
7 |
56,391,341 |
56,404,084 |
RGD:6480464 |
CTD |
| G |
Cct5 |
chaperonin containing Tcp1, subunit 5 (epsilon) |
|
decreases expression |
EXP |
2 |
83,681,785 |
83,692,937 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
affects response to substance |
ISO |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects response to substance |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases activity |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
increases expression |
EXP |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Clpx |
ClpX caseinolytic peptidase X homolog (E. coli) |
|
increases expression |
EXP |
8 |
69,530,991 |
69,572,018 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects response to substance |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases response to substance |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
affects response to substance |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cplx1 |
complexin 1 |
|
increases expression |
EXP |
14 |
1,732,344 |
1,763,172 |
RGD:6480464 |
CTD |
| G |
Cplx2 |
complexin 2 |
|
increases expression |
EXP |
17 |
16,314,592 |
16,322,938 |
RGD:6480464 |
CTD |
| G |
Cpz |
carboxypeptidase Z |
|
increases expression |
EXP |
14 |
80,857,371 |
80,880,592 |
RGD:6480464 |
CTD |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
multiple interactions |
EXP |
10 |
93,312,405 |
93,354,229 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
decreases expression |
EXP |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Cry1 |
cryptochrome 1 (photolyase-like) |
|
decreases expression |
EXP |
7 |
20,643,879 |
20,709,216 |
RGD:6480464 |
CTD |
| G |
Crym |
crystallin, mu |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
affects response to substance |
ISO |
16 |
77,485,217 |
78,605,037 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
affects expression |
EXP |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
affects localization |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
|
affects response to substance |
ISO |
17 |
87,545,893 |
87,772,079 |
RGD:6480464 |
CTD |
| G |
Cyb5b |
cytochrome b5 type B (outer mitochondrial membrane) |
|
increases expression |
EXP |
19 |
37,016,959 |
37,050,722 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
9 |
74,039,204 |
74,068,648 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
9 |
74,039,204 |
74,068,648 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects response to substance |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects response to substance |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects response to substance |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects response to substance |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
affects response to substance |
ISO |
7 |
75,318,788 |
75,336,382 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
affects expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddt |
D-dopachrome tautomerase |
|
affects expression |
EXP |
20 |
13,591,785 |
13,594,256 |
RGD:6480464 |
CTD |
| G |
Ddx10 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
|
increases expression |
EXP |
8 |
56,557,483 |
56,706,523 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
multiple interactions |
EXP |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
decreases expression |
EXP |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
increases expression |
EXP |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
decreases expression |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
EXP |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
decreases expression |
EXP |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
decreases expression |
EXP |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
multiple interactions |
EXP |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
affects expression |
EXP |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dpysl3 |
dihydropyrimidinase-like 3 |
|
decreases expression |
EXP |
18 |
36,620,669 |
36,680,355 |
RGD:6480464 |
CTD |
| G |
Dpysl5 |
dihydropyrimidinase-like 5 |
|
increases expression |
EXP |
6 |
25,557,972 |
25,642,140 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases expression |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases response to substance |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
affects activity |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases response to substance |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases response to substance |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases response to substance |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects activity |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases activity |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
decreases expression |
ISO |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
increases activity |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
affects response to substance |
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
increases response to substance |
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
multiple interactions |
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
increases expression |
EXP |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
multiple interactions |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
increases expression |
EXP |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
EXP |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
increases expression |
EXP |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
decreases expression |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
increases expression |
EXP |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
decreases expression |
EXP |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases response to substance |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
affects response to substance |
ISO |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
affects expression |
EXP |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
affects response to substance |
ISO |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
EXP |
4 |
165,448,027 |
165,456,481 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects response to substance |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects response to substance |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects response to substance |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor 2 |
|
multiple interactions |
ISO |
5 |
63,241,397 |
63,611,907 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA binding protein transcription factor, alpha subunit |
|
increases expression |
EXP |
11 |
24,323,963 |
24,352,754 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA binding protein transcription factor, alpha subunit |
|
multiple interactions |
EXP |
11 |
24,323,963 |
24,352,754 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
increases response to substance |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrg3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
|
increases expression |
EXP |
1 |
108,189,311 |
108,821,051 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamate decarboxylase 2 |
|
increases expression |
EXP |
17 |
96,259,430 |
96,321,857 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
decreases expression |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gcsh |
glycine cleavage system protein H (aminomethyl carrier) |
|
decreases expression |
EXP |
19 |
47,091,226 |
47,101,983 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
decreases expression |
EXP |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
decreases expression |
EXP |
X |
160,299,115 |
160,305,777 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases response to substance |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
affects expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
increases expression |
EXP |
15 |
51,279,770 |
51,371,053 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
increases expression |
EXP |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
increases expression |
EXP |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
decreases expression |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
affects expression |
EXP |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
decreases expression |
EXP |
5 |
172,341,135 |
172,386,772 |
RGD:6480464 |
CTD |
| G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
decreases expression |
EXP |
12 |
19,597,312 |
19,602,329 |
RGD:6480464 |
CTD |
| G |
Gnb3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
|
decreases expression |
EXP |
4 |
160,957,524 |
160,963,226 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
multiple interactions |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
decreases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
decreases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
affects expression |
EXP |
10 |
105,722,014 |
105,818,649 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
affects expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
increases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
increases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
ISO |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
|
decreases expression |
ISO |
1 |
96,308,548 |
96,345,931 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
increases expression |
EXP |
1 |
5,318,617 |
5,744,593 |
RGD:6480464 |
CTD |
| G |
Grm2 |
glutamate receptor, metabotropic 2 |
|
increases response to substance |
ISO |
8 |
111,837,086 |
111,850,133 |
RGD:6480464 |
CTD |
| G |
Grm2 |
glutamate receptor, metabotropic 2 |
|
multiple interactions |
ISO |
8 |
111,837,086 |
111,850,133 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
decreases expression |
EXP |
4 |
20,745,424 |
22,118,097 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
increases expression |
EXP |
4 |
20,745,424 |
22,118,097 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
multiple interactions |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
increases expression |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
decreases expression |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
decreases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm7 |
glutathione S-transferase, mu 7 |
|
increases expression |
EXP |
2 |
203,491,366 |
203,496,812 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hcn4 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
|
increases expression |
EXP |
8 |
62,629,828 |
62,667,248 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects response to substance |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hpca |
hippocalcin |
|
decreases expression |
EXP |
5 |
148,267,898 |
148,276,223 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases expression |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
EXP |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
increases response to substance |
ISO |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
ISO |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
decreases expression |
EXP |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
multiple interactions |
ISO |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
affects response to substance |
EXP |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
affects response to substance |
ISO |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
decreases expression |
EXP |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases response to substance |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
decreases expression |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
multiple interactions |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
decreases expression |
EXP |
3 |
105,374,429 |
105,394,861 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases activity |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects response to substance |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
increases expression |
EXP |
11 |
32,344,529 |
32,355,189 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
decreases expression |
ISO |
3 |
37,068,672 |
37,256,990 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
multiple interactions |
ISO |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
decreases expression |
ISO |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
EXP |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
decreases expression |
ISO |
11 |
35,025,118 |
35,116,500 |
RGD:6480464 |
CTD |
| G |
Kcnj9 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
|
decreases expression |
ISO |
13 |
88,311,500 |
88,318,875 |
RGD:6480464 |
CTD |
| G |
Lactb |
lactamase, beta |
|
increases expression |
EXP |
8 |
71,266,865 |
71,283,398 |
RGD:6480464 |
CTD |
| G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
affects localization |
EXP |
X |
6,908,285 |
6,951,772 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
affects response to substance |
ISO |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
|
affects response to substance |
ISO |
5 |
52,476,741 |
52,590,042 |
RGD:6480464 |
CTD |
| G |
Lzic |
leucine zipper and CTNNBIP1 domain containing |
|
increases expression |
EXP |
5 |
166,567,412 |
166,579,423 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
increases expression |
EXP |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
affects response to substance |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
multiple interactions |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
affects response to substance |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Map1a |
microtubule-associated protein 1A |
|
increases expression |
EXP |
3 |
108,097,119 |
108,111,060 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
EXP |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
decreases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
affects response to substance |
ISO |
8 |
67,313,472 |
67,542,723 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
decreases expression |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
decreases expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Marc1 |
mitochondrial amidoxime reducing component 1 |
|
affects response to substance |
ISO |
13 |
100,747,272 |
100,806,258 |
RGD:6480464 |
CTD |
| G |
Marc2 |
mitochondrial amidoxime reducing component 2 |
|
affects response to substance |
ISO |
13 |
100,809,306 |
100,838,648 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
affects expression |
EXP |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
decreases expression |
EXP |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
decreases expression |
EXP |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases response to substance |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases response to substance |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
increases expression |
EXP |
10 |
109,870,160 |
109,874,664 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
multiple interactions |
EXP |
1 |
42,111,647 |
42,116,465 |
RGD:6480464 |
CTD |
| G |
Mrpl32 |
mitochondrial ribosomal protein L32 |
|
increases expression |
EXP |
17 |
58,747,047 |
58,749,913 |
RGD:6480464 |
CTD |
| G |
Mrpl41 |
mitochondrial ribosomal protein L41 |
|
increases expression |
EXP |
3 |
5,120,299 |
5,121,217 |
RGD:6480464 |
CTD |
| G |
Mrpl41 |
mitochondrial ribosomal protein L41 |
|
multiple interactions |
EXP |
3 |
5,120,299 |
5,121,217 |
RGD:6480464 |
CTD |
| G |
Mrpl43 |
mitochondrial ribosomal protein L43 |
|
decreases expression |
EXP |
1 |
250,072,419 |
250,073,222 |
RGD:6480464 |
CTD |
| G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
|
multiple interactions |
EXP |
4 |
117,321,318 |
117,322,208 |
RGD:6480464 |
CTD |
| G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
|
increases expression |
EXP |
4 |
117,321,318 |
117,322,208 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
increases expression |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-nd2 |
mitochondrially encoded NADH dehydrogenase 2 |
|
multiple interactions |
ISO |
MT |
3,904 |
4,942 |
RGD:6480464 |
CTD |
| G |
Mt-nd2 |
mitochondrially encoded NADH dehydrogenase 2 |
|
decreases expression |
ISO |
MT |
3,904 |
4,942 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
decreases response to substance |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtpn |
myotrophin |
|
affects expression |
EXP |
4 |
62,896,762 |
62,924,175 |
RGD:6480464 |
CTD |
| G |
Myo5b |
myosin Vb |
|
affects response to substance |
ISO |
18 |
71,381,068 |
71,580,824 |
RGD:6480464 |
CTD |
| G |
Ncald |
neurocalcin delta |
|
affects expression |
EXP |
7 |
72,875,314 |
72,976,373 |
RGD:6480464 |
CTD |
| G |
Ndrg3 |
NDRG family member 3 |
|
decreases expression |
ISO |
3 |
147,454,138 |
147,571,926 |
RGD:6480464 |
CTD |
| G |
Ndrg3 |
NDRG family member 3 |
|
multiple interactions |
ISO |
3 |
147,454,138 |
147,571,926 |
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
increases expression |
EXP |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufb6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 |
|
increases expression |
EXP |
5 |
57,677,225 |
57,687,302 |
RGD:6480464 |
CTD |
| G |
Ndufs8 |
NADH dehydrogenase (ubiquinone) Fe-S protein 8 |
|
affects expression |
EXP |
1 |
206,433,596 |
206,437,478 |
RGD:6480464 |
CTD |
| G |
Ndufv2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2 |
|
increases expression |
EXP |
9 |
104,852,714 |
104,873,325 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
affects localization |
EXP |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
multiple interactions |
EXP |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfatc4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
affects localization |
EXP |
15 |
33,969,774 |
33,978,848 |
RGD:6480464 |
CTD |
| G |
Nfatc4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
multiple interactions |
EXP |
15 |
33,969,774 |
33,978,848 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases response to substance |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
increases expression |
EXP |
2 |
51,496,456 |
51,589,901 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects response to substance |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
ISO |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
increases response to substance |
ISO |
16 |
24,747,183 |
24,756,507 |
RGD:6480464 |
CTD |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
affects expression |
ISO |
16 |
24,747,183 |
24,756,507 |
RGD:6480464 |
CTD |
| G |
Npy2r |
neuropeptide Y receptor Y2 |
|
affects expression |
ISO |
2 |
150,554,962 |
150,556,108 |
RGD:6480464 |
CTD |
| G |
Npy2r |
neuropeptide Y receptor Y2 |
|
affects expression |
ISO |
2 |
150,554,962 |
150,556,108 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
multiple interactions |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
affects response to substance |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
affects response to substance |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nxph3 |
neurexophilin 3 |
|
increases expression |
EXP |
10 |
84,202,769 |
84,206,435 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
multiple interactions |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
affects response to substance |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Oprl1 |
opiate receptor-like 1 |
|
decreases expression |
ISO |
3 |
170,869,862 |
170,873,417 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases response to substance |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases expression |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
decreases expression |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
|
decreases expression |
EXP |
20 |
5,875,450 |
5,921,738 |
RGD:6480464 |
CTD |
| G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
|
decreases expression |
EXP |
1 |
2,287,981 |
2,304,638 |
RGD:6480464 |
CTD |
| G |
Pde1b |
phosphodiesterase 1B, calmodulin-dependent |
|
affects response to substance |
ISO |
7 |
142,401,489 |
142,427,626 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
affects response to substance |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
affects response to substance |
ISO |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde6c |
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
|
affects response to substance |
ISO |
1 |
242,459,653 |
242,515,102 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
decreases expression |
EXP |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
increases expression |
EXP |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
decreases expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
increases response to substance |
ISO |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
multiple interactions |
EXP |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
increases expression |
EXP |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
increases expression |
EXP |
12 |
40,491,393 |
40,495,593 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
increases expression |
EXP |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pfn2 |
profilin 2 |
|
affects expression |
EXP |
2 |
147,066,815 |
147,072,519 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
decreases expression |
EXP |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
decreases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
|
increases expression |
ISO |
13 |
12,315,824 |
12,565,692 |
RGD:6480464 |
CTD |
| G |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
|
affects expression |
ISO |
13 |
12,315,824 |
12,565,692 |
RGD:6480464 |
CTD |
| G |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
|
increases expression |
ISO |
13 |
12,315,824 |
12,565,692 |
RGD:6480464 |
CTD |
| G |
Pick1 |
protein interacting with PRKCA 1 |
|
increases response to substance |
ISO |
7 |
117,213,299 |
117,232,651 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
increases expression |
EXP |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
decreases expression |
EXP |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
decreases expression |
EXP |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases response to substance |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A (cyclophilin A) |
|
decreases expression |
EXP |
14 |
87,165,998 |
87,169,995 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
multiple interactions |
ISO |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
increases phosphorylation |
ISO |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
|
decreases expression |
EXP |
4 |
29,654,468 |
29,928,476 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
increases expression |
EXP |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
increases expression |
EXP |
15 |
3,986,290 |
4,030,352 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
multiple interactions |
EXP |
15 |
3,986,290 |
4,030,352 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
affects expression |
EXP |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Ppp3r2 |
protein phosphatase 3, regulatory subunit B, beta |
|
increases expression |
EXP |
5 |
66,423,374 |
66,424,369 |
RGD:6480464 |
CTD |
| G |
Ppp3r2 |
protein phosphatase 3, regulatory subunit B, beta |
|
multiple interactions |
EXP |
5 |
66,423,374 |
66,424,369 |
RGD:6480464 |
CTD |
| G |
Prdm2 |
PR domain containing 2, with ZNF domain |
|
affects response to substance |
ISO |
5 |
161,962,929 |
162,072,519 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
decreases expression |
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
increases expression |
EXP |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
increases expression |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
affects response to substance |
ISO |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
affects expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prokr2 |
prokineticin receptor 2 |
|
affects response to substance |
ISO |
3 |
120,139,415 |
120,147,532 |
RGD:6480464 |
CTD |
| G |
Prp2l1 |
proline rich protein 2-like 1 |
|
decreases expression |
EXP |
10 |
92,760,380 |
92,783,375 |
RGD:6480464 |
CTD |
| G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
affects response to substance |
ISO |
16 |
23,194,137 |
23,662,010 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
decreases expression |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
decreases expression |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma5 |
proteasome (prosome, macropain) subunit, alpha type 5 |
|
decreases expression |
EXP |
2 |
203,825,060 |
203,848,378 |
RGD:6480464 |
CTD |
| G |
Psmc3 |
proteasome (prosome, macropain) 26S subunit, ATPase 3 |
|
decreases expression |
EXP |
3 |
75,413,567 |
75,418,948 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases response to substance |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases response to substance |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases response to substance |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pum1 |
pumilio homolog 1 (Drosophila) |
|
increases expression |
ISO |
5 |
149,530,471 |
149,651,267 |
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rabep1 |
rabaptin, RAB GTPase binding effector protein 1 |
|
increases expression |
EXP |
10 |
57,746,747 |
57,847,498 |
RGD:6480464 |
CTD |
| G |
Rabif |
RAB interacting factor |
|
increases expression |
EXP |
13 |
47,437,336 |
47,448,832 |
RGD:6480464 |
CTD |
| G |
Raly |
RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse)) |
|
affects response to substance |
ISO |
3 |
145,275,832 |
145,337,808 |
RGD:6480464 |
CTD |
| G |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
|
affects response to substance |
ISO |
6 |
144,949,908 |
145,030,090 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
decreases expression |
EXP |
3 |
103,371,879 |
103,433,010 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects response to substance |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rgs17 |
regulator of G-protein signaling 17 |
|
affects response to substance |
ISO |
1 |
36,523,685 |
36,623,005 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
EXP |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
affects expression |
EXP |
13 |
85,533,882 |
85,540,173 |
RGD:6480464 |
CTD |
| G |
Rpl30 |
ribosomal protein L30 |
|
decreases expression |
EXP |
7 |
69,886,763 |
69,889,656 |
RGD:6480464 |
CTD |
| G |
Rps27a |
ribosomal protein S27a |
|
decreases expression |
EXP |
14 |
110,559,621 |
110,561,451 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases expression |
EXP |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Sept3 |
septin 3 |
|
decreases expression |
EXP |
7 |
120,650,069 |
120,669,466 |
RGD:6480464 |
CTD |
| G |
Sept5 |
septin 5 |
|
decreases expression |
EXP |
11 |
84,365,193 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Serpina5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
|
affects response to substance |
ISO |
6 |
128,156,901 |
128,161,334 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sgcz |
sarcoglycan zeta |
|
affects response to substance |
ISO |
16 |
57,281,677 |
58,399,526 |
RGD:6480464 |
CTD |
| G |
Sh3gl2 |
SH3-domain GRB2-like 2 |
|
decreases expression |
EXP |
5 |
104,129,280 |
104,308,317 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
multiple interactions |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
affects response to substance |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases response to substance |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
affects localization |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases activity |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
increases nitrosation |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases activity |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
multiple interactions |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects abundance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects response to substance |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases response to substance |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases response to substance |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
decreases expression |
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
multiple interactions |
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:6480464 |
CTD |
| G |
Smc3 |
structural maintenance of chromosomes 3 |
|
increases expression |
EXP |
1 |
259,822,480 |
259,865,602 |
RGD:6480464 |
CTD |
| G |
Smyd3 |
SET and MYND domain containing 3 |
|
affects response to substance |
ISO |
13 |
94,643,716 |
95,108,789 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sncb |
synuclein, beta |
|
increases expression |
EXP |
17 |
15,907,498 |
15,915,705 |
RGD:6480464 |
CTD |
| G |
Snx27 |
sorting nexin family member 27 |
|
increases expression |
EXP |
2 |
189,471,254 |
189,554,249 |
RGD:6480464 |
CTD |
| G |
Snx27 |
sorting nexin family member 27 |
|
multiple interactions |
EXP |
2 |
189,471,254 |
189,554,249 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects response to substance |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects response to substance |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects response to substance |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases response to substance |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Srpx |
sushi-repeat-containing protein, X-linked |
|
decreases expression |
EXP |
X |
24,833,279 |
24,904,349 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
increases expression |
EXP |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
Stat6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
|
decreases expression |
EXP |
7 |
67,623,534 |
67,642,283 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
decreases expression |
EXP |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
increases expression |
EXP |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
affects expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
increases expression |
EXP |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
ISO |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Taar1 |
trace-amine-associated receptor 1 |
|
multiple interactions |
ISO |
1 |
22,045,364 |
22,046,362 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tagln3 |
transgelin 3 |
|
increases expression |
EXP |
11 |
56,587,304 |
56,600,874 |
RGD:6480464 |
CTD |
| G |
Tas2r119 |
taste receptor, type 2, member 119 |
|
increases expression |
EXP |
2 |
84,651,696 |
84,652,703 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
affects response to substance |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Timm17b |
translocase of inner mitochondrial membrane 17 homolog B (yeast) |
|
decreases expression |
EXP |
X |
26,630,879 |
26,637,962 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases response to substance |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases activity |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tk2 |
thymidine kinase 2, mitochondrial |
|
increases expression |
EXP |
19 |
667,538 |
689,556 |
RGD:6480464 |
CTD |
| G |
Tle3 |
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
|
increases expression |
EXP |
8 |
65,485,758 |
65,531,052 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases response to substance |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnni1 |
troponin I type 1 (skeletal, slow) |
|
increases expression |
EXP |
13 |
48,830,442 |
48,841,258 |
RGD:6480464 |
CTD |
| G |
Tnni3 |
troponin I type 3 (cardiac) |
|
increases expression |
ISO |
1 |
68,028,198 |
68,031,882 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
affects response to substance |
ISO |
7 |
54,321,033 |
54,430,706 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
|
affects response to substance |
ISO |
1 |
225,377,097 |
226,276,992 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases expression |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
decreases expression |
EXP |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
decreases expression |
EXP |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb4b |
tubulin, beta 4B class IVb |
|
decreases expression |
EXP |
3 |
3,387,050 |
3,389,500 |
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
EXP |
20 |
3,060,224 |
3,090,776 |
RGD:6480464 |
CTD |
| G |
Tufm |
Tu translation elongation factor, mitochondrial |
|
decreases expression |
EXP |
1 |
185,631,333 |
185,634,940 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
multiple interactions |
EXP |
X |
12,926,049 |
12,944,522 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
affects localization |
EXP |
X |
12,926,049 |
12,944,522 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
decreases expression |
EXP |
X |
12,926,049 |
12,944,522 |
RGD:6480464 |
CTD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
affects expression |
EXP |
7 |
32,719,959 |
32,750,002 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
decreases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
EXP |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Usp48 |
ubiquitin specific peptidase 48 |
|
affects response to substance |
ISO |
5 |
156,351,117 |
156,418,283 |
RGD:6480464 |
CTD |
| G |
Vcsa2 |
variable coding sequence A2 |
|
decreases expression |
EXP |
14 |
21,438,442 |
21,444,907 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
decreases expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdac2 |
voltage-dependent anion channel 2 |
|
decreases expression |
EXP |
15 |
2,515,297 |
2,528,969 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Zfp385d |
zinc finger protein 385D |
|
affects response to substance |
ISO |
15 |
6,526,420 |
6,788,782 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
affects response to substance |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
affects response to substance |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
Term paths to the root
|